Works in Leukemia & Lymphoma, 2023, Vol 64, Issue 2

Results: 35
    1
    2
    3
    4

    First clinical description of a pedigree with complete NAF1 deletion.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 487, doi. 10.1080/10428194.2022.2148377
    By:
    • Galtier, Jean;
    • Dimicoli-Salazar, Sophie;
    • Trimouille, Aurélien;
    • Lainey, Elodie;
    • Revy, Patrick;
    • Bidet, Audrey;
    • Vial, Yoann;
    • Forcade, Edouard;
    • Negrier-Leibreich, Marie-Laure;
    • Rivière, Etienne;
    • Tinat, Julie;
    • Le Meur, Nathalie;
    • Ménard, Christelle;
    • Pigneux, Arnaud;
    • Leguay, Thibaut;
    • Dumas, Pierre-Yves;
    • Ibrahima, Ba;
    • Kannengiesser, Caroline
    Publication type:
    Article
    5

    Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative study.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 319, doi. 10.1080/10428194.2022.2148376
    By:
    • Mills, Georgia S.;
    • Di Ciaccio, Pietro R.;
    • Tang, Catherine;
    • Chadwick, Verity;
    • Mason, Kylie D.;
    • Campbell, Belinda A.;
    • Shipton, Michael J.;
    • Shanavas, Mohamed;
    • Morris, Kirk L.;
    • Greenwood, Matthew;
    • Langfield, Jenna;
    • Kidson-Gerber, Giselle;
    • Eslick, Renee;
    • Badoux, Xavier;
    • Yannakou, Costas K.;
    • Gangatharan, Shane A.;
    • Bilmon, Ian;
    • Hamad, Nada
    Publication type:
    Article
    6

    Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 468, doi. 10.1080/10428194.2022.2148221
    By:
    • Nahi, Hareth;
    • Usmani, Saad Z.;
    • Mateos, Maria-Victoria;
    • van de Donk, Niels W. C. J.;
    • Oriol, Albert;
    • Plesner, Torben;
    • Bandyopadhyay, Nibedita;
    • Hellemans, Peter;
    • Tromp, Brenda;
    • Nnane, Ivo;
    • Zemlickis, Donna;
    • Chari, Ajai;
    • Moreau, Philippe
    Publication type:
    Article
    7
    8
    9

    ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 483, doi. 10.1080/10428194.2022.2148217
    By:
    • Chiaretti, Sabina;
    • Taherinasab, Akram;
    • Della Starza, Irene;
    • Canichella, Martina;
    • Ansuinelli, Michela;
    • De Propris, Maria Stefania;
    • Messina, Monica;
    • Spinelli, Orietta;
    • Santoro, Alessandra;
    • De Novi, Lucia Anna;
    • Cardinali, Deborah;
    • Schipani, Mattia;
    • Arena, Valentina;
    • Bassan, Renato;
    • Guarini, Anna;
    • Foà, Robin
    Publication type:
    Article
    10
    11
    12
    13
    14

    A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 473, doi. 10.1080/10428194.2022.2148212
    By:
    • Assouline, Sarit;
    • Michaelis, Laura C.;
    • Othus, Megan;
    • Hay, Annette E.;
    • Walter, Roland B.;
    • Jacoby, Meagan A.;
    • Schroeder, Mark A.;
    • Uy, Geoffrey L.;
    • Law, Lisa Y.;
    • Cheema, Faisal;
    • Sweet, Kendra L.;
    • Asch, Adam S.;
    • Liu, Jijun;
    • Moseley, Anna B.;
    • Maher, Tracy;
    • Kingsbury, Laura L.;
    • Fang, Min;
    • Radich, Jerald;
    • Little, Richard F.;
    • Erba, Harry P.
    Publication type:
    Article
    15

    Central nervous system involvement by mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 371, doi. 10.1080/10428194.2022.2148211
    By:
    • McLaughlin, Nicole;
    • Wang, Yucai;
    • Witzig, Thomas;
    • Villasboas, Jose;
    • Habermann, Thomas;
    • Inwards, David;
    • Bennani, Nora;
    • Thanarajasingam, Gita;
    • Nowakowski, Grzegorz;
    • Porrata, Luis;
    • Thompson, Carrie;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Ansell, Stephen;
    • Paludo, Jonas
    Publication type:
    Article
    16

    Efficacy and safety of obinutuzumab combined with fludarabine and cyclophosphamide (FCG) or bendamustine (BG) in relapsed or refractory CLL patients followed by maintenance therapy with obinutuzumab for responding patients.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 478, doi. 10.1080/10428194.2022.2148210
    By:
    • Kutsch, Nadine;
    • Holmes, Emily Eva;
    • Robrecht, Sandra;
    • Schüler, Gudrun;
    • Vehling-Kaiser, Ursula;
    • Decker, Thomas;
    • Müller-Hagen, Sigrun;
    • Heinisch, Karin;
    • Böttcher, Sebastian;
    • Ritgen, Matthias;
    • Kreuzer, Karl-Anton;
    • Stilgenbauer, Stephan;
    • Fink, Anna Maria;
    • Fischer, Kirsten;
    • Eichhorst, Barbara;
    • Hallek, Michael;
    • Wendtner, Clemens-Martin
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 462, doi. 10.1080/10428194.2022.2140285
    By:
    • Chen Wongworawat, Yan;
    • Eskandari, Ghazaleh;
    • Gaikwad, Amos;
    • Marcogliese, Andrea N.;
    • Ferguson, Lizmery S.;
    • Brackett, Julienne;
    • Punia, Jyotinder N.;
    • Elghetany, M. Tarek;
    • Kulkarni, Reshma;
    • Rao, Pulivarthi H.;
    • Ringrose, Jo;
    • Lopez-Terrada, Dolores H.;
    • Roy, Angshumoy;
    • Curry, Choladda V.;
    • Fisher, Kevin E.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34

    Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 273, doi. 10.1080/10428194.2022.2136947
    By:
    • Shahzad, Moazzam;
    • Chaudhary, Sibgha Gull;
    • Tariq, Ezza;
    • Mushtaq, Ali Hassan;
    • Anwar, Iqra;
    • Ahmed, Nausheen;
    • Bansal, Rajat;
    • Lutfi, Forat;
    • Balusu, Ramesh;
    • Abdelhakim, Haitham;
    • Yacoub, Abdulraheem;
    • Hematti, Peiman;
    • Singh, Anurag K.;
    • McGuirk, Joseph P.;
    • Mushtaq, Muhammad Umair
    Publication type:
    Article
    35